← Open Payments lookup

IAN SMALLING: Open Payments

NPI 1114971033 · SUGAR LAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,035 in 46 payments from 13 companies in 2025. Trend: 2023 $1,469 · 2024 $1,076 · 2025 $1,035

Food & beverage: $1,035
CompanyPaymentsAmount
Axsome Therapeutics, Inc.8$179
E.R. Squibb & Sons, L.L.C.6$157
ABBVIE INC.7$139
Vanda Pharmaceuticals Inc.5$100
Corium, LLC4$91
Takeda Pharmaceuticals U.S.A., Inc.3$86
Lundbeck LLC3$69
Otsuka America Pharmaceutical, Inc.3$64
Neurocrine BioSciences, Inc.2$59
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$43

Products named: Auvelity, COBENFY, VRAYLAR, REXULTI, FANAPT, Azstarys, TRINTELLIX, INGREZZA.

Industry payments across TX — which companies pay providers there.